Hiv+ Six months ago
Jul 9, 2006
Hello, and thank you for your help, I am a recently diagnosed 35 yr old male, cd4's @ 420 VL @ 300,000+, and just got over a bout of shingles exceptionally well with acyclovir 800mg x 5 tabs x 7 days...My doc wants to start meds already...choosing a first line of Kaletra, Viread, and 3TC(lamivudine)...I am being offered this cocktail as a clinical trial, what do you think?
Response from Dr. Young
Thanks for your post.
First off, I'd agree with your doctor about the initiation of treatment-- you've got a CD4 count that's approaching the conventional threshold (~350) and a pretty high viral load (a predictor of more rapid than average CD4 decline).
My favorite approach for first-line patients is to offer clinical trial options-- this way the community learns of the benefits and liabilities of treatments; to the patients, there's the benefit of free medications and HIV-related health monitoring.
The regimen that you're offered is very potent and generally very well tolerated. I've advocated the use of boosted PIs (such as lopinavir/ritonavir-- Kaletra) for many first-line patients, particulary becuase of the reduction in risk of drug resistance. The combination of tenfovir (Viread), 3TC and lopinavir/ritonavir doesn't have the lowest pill count, but it's pill burden of 6 pills daily isn't prohibitive. Be sure that your doctor evaluates your kidney function and blood lipids before and during treatment, since these represent the characteristic toxicities of the regimen.
I hope this helps, let us know how your treatment goes. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.